Association of the interleukin-10 -592A/C, -1082G/A and -819T/C gene polymorphisms with type 2 diabetes: a meta-analysis.
There is more evidence that interleukin-10 (IL-10), as a multifunctional regulatory cytokine of inflammatory responses, may have an important role in type 2 diabetes (T2D). However, genetic association studies that evaluated the relationship between IL-10 gene variants and T2D have produced conflicting results. The aim of this study was to determine whether the IL-10 gene polymorphisms (-592A/C, -1082G/A, -819T/C) conferred susceptibility to T2D through a meta-analysis. A comprehensive search was conducted to examine all the eligible studies. A total of 9 studies involving 2838 T2D patients and 2773 controls were considered in the meta-analysis. Overall, there was no significant association between IL-10 -592A/C and T2D (A vs C: OR=0.93, P=0.625; AA+AC vs CC: OR=0.89, P=0.511; AA vs AC+CC: OR=0.93, P=0.821). We failed to find the association between the IL-10 -1082G allele and T2D (OR=1.04, P=0.430), but the genotypes of the IL-10 -1082G/A polymorphism conferred a risk for the development of T2D (GA vs AA: OR=1.21, P=0.027; GG+GA vs AA: OR=1.17, P=0.048). Analysis of the -819T/C polymorphism revealed no significant association with T2D (T vs C: OR=1.04, P=0.853; TT+TC vs CC: OR=1.07, P=0.834; TT vs TC+CC: OR=1.08, P=0.824). In conclusion, the present meta-analysis suggests association between the IL-10 -1082G/A polymorphism and T2D. However, additional well-designed and larger scale primary studies are required to further evaluate the IL-10 gene polymorphisms and T2D.